Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.

Ram H, Rao JR, Tewari AK, Banerjee PS, Sharma AK.

Parasitol Res. 2013 Jul;112(7):2487-94. doi: 10.1007/s00436-013-3414-3. Epub 2013 Apr 10.

PMID:
23572047
2.

Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.

Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Grzybowski M, Dlugonska H.

Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.

PMID:
21087690
3.

Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.

Lau YL, Thiruvengadam G, Lee WW, Fong MY.

Parasitol Res. 2011 Sep;109(3):871-8. doi: 10.1007/s00436-011-2315-6. Epub 2011 Apr 1.

PMID:
21455621
4.

Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.

Costa-Silva TA, Meira CS, Ferreira IM, Hiramoto RM, Pereira-Chioccola VL.

Exp Parasitol. 2008 Nov;120(3):227-34. doi: 10.1016/j.exppara.2008.07.015. Epub 2008 Jul 31.

PMID:
18706414
5.

The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.

Zheng B, Lu S, Tong Q, Kong Q, Lou D.

Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.

PMID:
23928460
6.

Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.

Cong H, Gu QM, Jiang Y, He SY, Zhou HY, Yang TT, Li Y, Zhao QL.

Parasite Immunol. 2005 Jan-Feb;27(1-2):29-35.

7.
8.

Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.

Yan HK, Yuan ZG, Petersen E, Zhang XX, Zhou DH, Liu Q, He Y, Lin RQ, Xu MJ, Chen XL, Zhong XL, Zhu XQ.

Exp Parasitol. 2011 May;128(1):38-43. doi: 10.1016/j.exppara.2011.02.005. Epub 2011 Feb 15.

PMID:
21310148
9.

Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route.

Mévélec MN, Mercereau-Puijalon O, Buzoni-Gatel D, Bourguin I, Chardès T, Dubremetz JF, Bout D.

Parasite Immunol. 1998 Apr;20(4):183-95.

10.

Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.

Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, Zhou H, He S.

Parasit Vectors. 2013 Mar 13;6:63. doi: 10.1186/1756-3305-6-63.

11.

Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.

Lau YL, Fong MY.

Exp Parasitol. 2008 Jul;119(3):373-8. doi: 10.1016/j.exppara.2008.03.016. Epub 2008 Apr 8.

PMID:
18457835
12.

Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.

Li WS, Chen QX, Ye JX, Xie ZX, Chen J, Zhang LF.

Parasitol Res. 2011 Sep;109(3):637-44. doi: 10.1007/s00436-011-2296-5. Epub 2011 Mar 15.

PMID:
21404064
13.

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.

Lu G, Zhou A, Meng M, Wang L, Han Y, Guo J, Zhou H, Cong H, Zhao Q, Zhu XQ, He S.

BMC Infect Dis. 2014 Dec 20;14:3862. doi: 10.1186/s12879-014-0706-x.

14.

Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.

Chen J, Huang SY, Li ZY, Yuan ZG, Zhou DH, Petersen E, Zhang NZ, Zhu XQ.

Vaccine. 2013 Mar 25;31(13):1734-9. doi: 10.1016/j.vaccine.2013.01.027. Epub 2013 Jan 29.

PMID:
23370151
15.

Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.

Fang R, Feng H, Hu M, Khan MK, Wang L, Zhou Y, Zhao J.

Vet Parasitol. 2012 Jun 8;187(1-2):140-6. doi: 10.1016/j.vetpar.2011.12.007. Epub 2011 Dec 19.

PMID:
22336771
16.

Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.

Yang CD, Chang GN, Chao D.

Parasitol Res. 2004 Jan;92(1):58-64. Epub 2003 Nov 6.

PMID:
14605877
17.

[Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].

Li JH, Wu ST, Weng YB, Gan Y, Liu HB, Liu ML, Zhang RL, Gao ST, Huang DN, Geng YJ.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007 Jun;25(3):217-21. Chinese.

PMID:
18038782
18.

Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.

Wang HL, Li YQ, Yin LT, Meng XL, Guo M, Zhang JH, Liu HL, Liu JJ, Yin GR.

PLoS One. 2013 Aug 15;8(8):e70884. doi: 10.1371/journal.pone.0070884. eCollection 2013.

19.

Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.

Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H.

Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.

PMID:
22445587
20.

Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection.

Costa-Silva TA, Borges MM, Galhardo CS, Pereira-Chioccola VL.

Acta Trop. 2012 Dec;124(3):203-9. doi: 10.1016/j.actatropica.2012.08.013. Epub 2012 Aug 23.

Supplemental Content

Support Center